| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |